BHCM
KROS icon

Brevan Howard Capital Management’s Keros Therapeutics KROS Stock Holding History

Brevan Howard Capital Management’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$936K Buy
70,149
+4,305
+7% +$57.5K 0.01% 1014
2025
Q1 		$671K Buy
65,844
+54,658
+489% +$557K 0.01% 591
2024
Q4 		$177K Buy
11,186
+5,468
+96% +$86.6K ﹤0.01% 898
2024
Q3 		$332K Buy
+5,718
New +$332K ﹤0.01% 756